Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration

Author(s):
Wang, Y.; Parlevliet, E.T.; Geerling, J.J.; Tuin, S.J.L. van der; Zhang, H.; Bieghs, V.; Jawad, A.H.M.; Shiri-Sverdlov, R.; Bot, I.; Jager, S.C.A. de; Havekes, L.M.; Romijn, J.A.; Dijk, K.W. van; Rensen, P.C.N. (0000-0002-8455-4988)
Published
2014
Publication type
Article / Letter to editor
cholesterolexendin-4inflammationmacrophage contentmonocyte recruitmentoxidized LDL
Date issued
2014-02-28
Language
English
Is part of
British Journal of Pharmacology (2014), Vol. 171, no. 3, p. 723-734
hdl
1887/108042
doi
10.1111/bph.12490